RAPT Competitors & Alternatives
Compare RAPT Therapeutics Inc with similar stocks in the same industry
Biotechnology
RAPT
Main Stock$58.02
Tradestie Score
53
Market Cap
$450.49M
Revenue Growth
-1.0%
Analyst Upside
0.0%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.83
|
$1.78B | - | 55 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$25.24
|
$1.78B | - | 55 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$19.31
|
$1.74B | - | 56 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$37.69
|
$1.68B | - | 57 | Compare |
|
MNKD
Mannkind Corporation
|
$3.80
|
$1.65B | - | 51 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$38.38
|
$1.63B | - | 50 | Compare |
|
BHVN
Biohaven Ltd.
|
$13.37
|
$1.57B | - | 51 | Compare |
|
VCEL
Vericel Corporation
|
$46.05
|
$1.56B | 95.8 | 52 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$106.02
|
$1.55B | - | 56 | Compare |
|
HRMY
Harmony Biosciences Holdings, Inc. Common Stock
|
$35.60
|
$1.55B | 14.2 | 59 | Compare |
More RAPT Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry